Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | macrophage migration inhibitory factor (glycosylation-inhibiting factor) | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | 0 | Inhibition of LPS-induced TNFalpha release in RAW 267.4 macrophages after 16 hrs | ChEMBL. | 17385848 |
IC50 (binding) | = 0.13 uM | Inhibition of MIF tautomerase activity by spectrophotometric assay | ChEMBL. | 17385848 |
IC50 (binding) | = 0.13 uM | Inhibition of MIF tautomerase activity by spectrophotometric assay | ChEMBL. | 17385848 |
Survival (functional) | = 65 % | Survival of CLP-induced BALB/c mouse at 4 mg/kg, ip after 3 days | ChEMBL. | 17385848 |
Survival (functional) | = 65 % | Survival of CLP-induced BALB/c mouse at 4 mg/kg, ip after 3 days | ChEMBL. | 17385848 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.